Highmark Medicare Advantage Medical Policy in West Virginia

Section: CMS National Guidelines
Number: N-131
Topic: Treatment of Obesity and Bariatric Surgery for Treatment of Morbid Obesity - NCD 40.5, 100.1, 100.8, 100.11, 100.14
Effective Date: February 12, 2012
Issued Date: July 9, 2012

General Policy

Obesity may be caused by medical conditions such as hypothyroidism, Cushing's disease, hypothalamic lesions, or can aggravate a number of cardiac and respiratory diseases, as well as diabetes and hypertension.  Non-surgical services in connection with the treatment of obesity are covered services when such services are an integral and necessary part of a course of treatment for one of these illnesses. Certain designated surgical services for the treatment of obesity are covered for members who have a BMI ≥35, have at least one comorbidity related to obesity and have been previously unsuccessful with the medical treatment of obesity.

Bariatric surgery procedures are performed to treat comorbid conditions associated with morbid obesity. Two types of surgical procedures are employed. Malabsorptive procedures divert food from the stomach to a lower part of the digestive tract where the normal mixing of digestive fluids and absorption of nutrients cannot occur. Restrictive procedures restrict the size of the stomach and decrease intake. Surgery can combine both types of procedures.

Indications and Limitations of Coverage

Treatment of Obesity

Obesity is not in and of itself sufficient to support medical necessity.  The patient must have morbid obesity and a V code diagnoses which describes a BMI ≥35 and another condition which was either caused by or aggravated by the obesity.  Morbid obesity and a V code diagnoses which describes a BMI ≥35, and another diagnosis code that supports medical necessity as indicated in this policy must be reported on the claim.

Type 2 diabetes mellitus (T2DM) is a comorbidity for purpose of this policy.

Supplemental Fasting

Supplemental fasting is a type of very low calorie weight reduction regimen used to achieve rapid weight loss. The reduced calorie intake is supplemented by a mixture of protein, carbohydrates, vitamins, and minerals. Serious questions exist about the safety of prolonged adherence for two months or more to a very low calorie weight reduction regimen as a general treatment of obesity, because of instances of cardiopathology and sudden death, as well as possible loss of body protein. Therefore, supplemented fasting is not covered as a general treatment for obesity.

In cases where weight loss is necessary before surgery in order to ameliorate the complications posed by obesity when it coexists with pathological conditions such as cardiac and respiratory diseases, diabetes, or hypertension (and other more conservative techniques to achieve this end are not regarded as appropriate), supplemented fasting with adequate monitoring of the patient is covered on an individual consideration basis. The risks associated with the achievement of rapid weight loss must be carefully balanced against the risk posed by the condition requiring surgical treatment.

Bariatric Surgery for the Treatment of Morbid Obesity
The following designated surgical services for the treatment of obesity are covered for members if:

  1. The individual has a body-mass index ≥35
  2. The individual has at least one comorbidity related to obesity; and
  3. The individual has been previously unsuccessful with medical treatment for obesity.


These procedures are only covered when performed at facilities that are:

  1. Certified by the American College of Surgeons as a Level 1 Bariatric Surgery Center (program standards and requirements in effect on February 15, 2006); or
  2. Certified by the American Society of Bariatric Surgery as a Bariatric Surgery Center of Excellence (program standards and requirements in effect on February 15, 2006.

A list of approved facilities and their approval dates are listed and maintained on the CMS Coverage Web site at http://www.cms.hhs.gov/center/coverage.asp.and published in the Federal Register.

Noncovered Indications

Nationally Non-Covered Indications

  1. Treatments for obesity alone are non-covered.
  2. Supplemental fasting is not covered as a general treatment for obesity.
  3. Open and laparoscopic RYGBP, open and laparoscopic BPD/DS and LAGB are non-covered for members who have a BMI <35 and T2DM.

The evidence is not adequate to conclude that the following bariatric surgery procedures are reasonable and necessary.  Therefore, they are non-covered.  A provider cannot bill the member for the denied service unless the provider has given advance written notice, informing the member that the service may be deemed not medically necessary and providing an estimate of the cost. The member must agree in writing to assume financial responsibility, in advance of receiving the service. The signed agreement, in the form of a Pre-Service Denial Notice, should be maintained in the provider's records.

The treatment of morbid obesity unrelated to such medical conditions listed above is not considered reasonable and necessary and is not covered under the program. A provider cannot bill the member for the denied service unless the provider has given advance written notice, informing the member that the service may be deemed not medically necessary and providing an estimate of the cost. The member must agree in writing to assume financial responsibility, in advance of receiving the service. The signed agreement, in the form of a Pre-Service Denial Notice, should be maintained in the provider's records.

Place of Service: Inpatient

Documentation Requirements

The documentation must support the medical necessity of the service and be available upon request.

NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

436444364543659437704377143772
437734377443775438424384343845
43846 4384743848438864388743888
43999     

Coding Guidelines

Publications

Provider News

04/2012, Medicare Advantage Medical Policy N-131 to include place of service designation

References

Title XVIII of the Social Security Act, Section 1862(a)(7). This section excludes routine physical examinations.

Title XVIII of the Social Security Act, Section 1862(a)(1)(A) states that no payment shall be made for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury.

Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider for any claim that lacks the necessary information to process the claim.

Medicare Internet On-Line Manual Pub. 100-3, Chapter 1, Section 40.5, 100.1, 100.8, 100.11, 100.14

Medicare Internet On-Line Manual Pub. 100-04

Transmittal 23, Change Request 3502

Transmittal 54, Change Request 5013

Transmittal 931, Change Request 5013

Transmittal 1728, Change Request 6419

Transmittal 100, Change Request 6419

www.cms.gov
www.medicare.gov

Attachments

Procedure Code Attachments

Diagnosis Codes

ICD-9 Diagnosis Codes

(Applicable to the medical treatment of obesity and procedure codes 43644, 43645, 43770-43774, 43843-43848, and 43886-43888)

Covered Diagnosis Codes

Report 278.01 and one of the following diagnoses to support a BMI of > 35 or morbid obesity:

V85.35-V85.39V85.41-V85.45  

In addition, at least one of the following diagnoses supporting an obesity related comorbidity must also be reported;

243244.0244.1244.2
244.3244.8244.9250.00-250.93
253.9255.0277.7278.8
327.20-327.29401.0401.1-401.9414.00-414.05
416.9425.4425.9428.0
428.9459.81491.1491.20-491.22
491.8491.9492.0492.8
493.00-493.02493.20-493.22493.90-493.92530.11
530.19530.20-530.21530.82571.8
715.09715.15-715.17715.25-715.27715.35-715.37
715.89715.95-715.97780.51780.57

Non-covered Diagnosis Codes

278.00   

ICD-10 Diagnosis Codes

Glossary

TermDescription

Adjustable Gastric Banding (AGB)

AGB achieves weight loss by gastric restriction only.  A band creating a gastric pouch with a capacity of approximately 15 to 30 cc's encircles the uppermost portion of the stomach.  The band is an inflatable doughnut-shaped balloon, the diameter of which can be adjusted in the clinic by adding or removing saline via a port that is positioned beneath the skin.  The bands are adjustable, allowing the size of the gastric outlet to be modified as needed, depending on the rate of a patient's weight loss.  ABG procedures are laparoscopic only.

 

Biliopancreatic Diversion with Duodenal Switch (BPD/DS)

BPD achieves weight loss by gastric restriction and malabsorption.  The stomach is partially resected, but the remaining capacity is generous compared to that achieved with RYGBP.  As such, patients eat relatively normal-sized meals and do not need to restrict intake radically since the most proximal areas of the small intestine (i.e., the duodenum and jejunum) are bypassed, and substantial malabsorption occurs.  The partial BPD with duodenal switch is a variant of the BPD procedure.  It involves resection of the greater curvature of the stomach, preservation of the pyloric sphincter, and transaction of the duodenum above the ampulla of Vater with a duodeno-ileal anastomosis and a lower ileo-ileal anastomosis.  BPD/DS procedures can be open or laparoscopic.

 

Gastric Balloon

A gastric balloon is a medical device developed for use as a temporary adjunct to diet and behavior modification to reduce the weight of patients who fail to lose weight with those measures alone.  It is inserted into the stomach to reduce the capacity of the stomach and to affect early satiety.

 

Roux-en-Y Gastric Bypass (RYGBP)

The RYGBP achieves weight loss by gastric restriction and malabsorption.  Reduction of the stomach to a small gastric pouch (30 cc) results in feelings of satiety following even small meals.  This small pouch is connected to a segment of the jejunum, bypassing the duodenum and very proximal small intestine, thereby reducing absorption.  RYGBP procedures can be open or laparoscopic.

 

Sleeve Gastrectomy

Sleeve gastrectomy is a 70%-80% greater curvature gastrectomy (sleeve resection of the stomach) with continuity of the gastric lesser curve being maintained while simultaneously reducing stomach volume.  It may be the first step in a two-stage procedure when performing RYGBP.  Sleeve gastrectomy procedures can be open or laparoscopic.

 

Vertical Gastric Banding (VGB)

The VGB achieves weight loss by gastric restriction only.  The upper part of the stomach is stapled, creating a narrow gastric inlet or pouch that remains connected with the remainder of the stomach.  In addition, a non-adjustable band is placed around this new inlet in an attempt to prevent future enlargement of the stoma (opening).  As a result, patients experience a sense of fullness after eating small meals.  Weight loss from this procedure results entirely from eating less.  VGB procedures are essentially no longer performed.






This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Medical policies are designed to supplement the terms of a member's contract. The member's contract defines the benefits available; therefore, medical policies should not be construed as overriding specific contract language. In the event of conflict, the contract shall govern.

Medical policies do not constitute medical advice, nor the practice of medicine. Rather, such policies are intended only to establish general guidelines for coverage and reimbursement under Medicare Advantage plans. Application of a medical policy to determine coverage in an individual instance is not intended and shall not be construed to supercede the professional judgment of a treating provider. In all situations, the treating provider must use his/her professional judgment to provide care he/she believes to be in the best interest of the patient, and the provider and patient remain responsible for all treatment decisions.

Medicare Advantage retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Medicare Advantage. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.